CRR Tool
Capital Requirements Regulation (CRR)
Article 107
Article 107 - Approaches to credit risk
Table of content
Article 387 - Subject matterArticle 389 - DefinitionQ&AArticle 390 - Calculation of the exposure valueITS/RTSQ&AArticle 391 - Definition of an institution for large exposures purposesITS/RTSQ&AArticle 392 - Definition of a large exposureQ&AArticle 393 - Capacity to identify and manage large exposuresArticle 394 - Reporting requirementsITS/RTSQ&AArticle 395 - Limits to large exposuresQ&AOPGLArticle 396 - Compliance with large exposures requirementsGLArticle 397 - Calculating additional own funds requirements for large exposures in the trading bookArticle 398 - Procedures to prevent institutions from avoiding the additional own funds requirementArticle 399 - Eligible credit mitigation techniquesQ&AArticle 400 - ExemptionsQ&AArticle 401 - Calculating the effect of the use of credit risk mitigation techniquesQ&AOPArticle 402 - Exposures arising from mortgage lendingQ&AArticle 403 - Substitution approachQ&AGL
Article 429 - Calculation of the leverage ratioQ&AArticle 429a - Exposures excluded from the total exposure measureQ&ADCArticle 429b - Calculation of the exposure value of assetsQ&AArticle 429c - Calculation of the exposure value of derivativesQ&AArticle 429d - Additional provisions on the calculation of the exposure value of written credit derivativesQ&AArticle 429e - Counterparty credit risk add-on for securities financing transactionsQ&AArticle 429f - Calculation of the exposure value of off-balance-sheet itemsQ&AArticle 429g - Calculation of the exposure value of regular-way purchases and sales awaiting settlementQ&A
Article 430 - Reporting on prudential requirements and financial informationITS/RTSQ&AArticle 430a - Specific reporting obligationsQ&AArticle 430b - Specific reporting requirements for market riskITS/RTSArticle 430c - Feasibility report on the integrated reporting system
Article 456 - Delegated actsQ&AOPArticle 457 - Technical adjustments and correctionsArticle 458 - Macroprudential or systemic risk identified at the level of a Member StateOPArticle 459 - Prudential requirementsArticle 460 - LiquidityITS/RTSQ&AArticle 461 - Review of the phasing-in of the liquidity coverage requirementArticle 461a - Alternative standardised approach for market riskArticle 462 - Exercise of the delegationArticle 463 - Objections to regulatory technical standardsArticle 464 - European Banking Committee
Article 107
Approaches to credit risk
1.
Institutions shall apply either the Standardised Approach provided for in Chapter 2 or, if permitted by the competent authorities in accordance with Article 143, the Internal Ratings Based Approach provided for in Chapter 3 to calculate their risk-weighted exposure amounts for the purposes of points (a) and (f) of Article 92(3).
2.
For trade exposures and for default fund contributions to a central counterparty, institutions shall apply the treatment set out in Chapter 6, Section 9 to calculate their risk-weighted exposure amounts for the purposes of points (a) and (f) of Article 92(3). For all other types of exposures to a central counterparty, institutions shall treat those exposures as follows:
(a)
as exposures to an institution for other types of exposures to a qualifying CCP;
3.
For the purposes of this Regulation, exposures to a third-country investment firm, a third-country credit institution and a third-country exchange shall be treated as exposures to an institution only where the third country applies prudential and supervisory requirements to that entity that are at least equivalent to those applied in the Union.
4.
For the purposes of paragraph 3, the Commission may adopt, by way of implementing acts, and subject to the examination procedure referred to in Article 464(2), a decision as to whether a third country applies prudential supervisory and regulatory requirements at least equivalent to those applied in the Union. In the absence of such a decision, until 1 January 2015, institutions may continue to treat exposures to the entities referred to in paragraph 3 as exposures to institutions provided that the relevant competent authorities have approved the third country as eligible for that treatment before 1 January 2014.
ITS/RTS based on this article
Related documents
Q&A under review 2016_2739
Submitted: 19/05/2016
Art. 107
Rejected Q&A 2015_1806
Submitted: 06/02/2015
Art. 107
Final Q&A 2015_2138
Updated: 26/03/2021
Published: 06/01/2017
Art. 107
Final Q&A 2015_1968
Updated: 26/03/2021
Published: 30/04/2015
Art. 107
Final Q&A 2013_529
Updated: 26/03/2021
Published: 10/02/2017
Art. 107
Final Q&A 2013_677
Updated: 26/03/2021
Published: 03/10/2014
Art. 107
Final Q&A 2013_177
Updated: 26/03/2021
Published: 26/09/2014
Art. 107
Final Q&A 2013_172
Updated: 26/03/2021
Published: 22/11/2013
Art. 107(2)
EBA/OP/2021/12
Published: 17/11/2021
Art. 107(3)
EBA/OP/2021/13
Published: 17/11/2021
Art. 107(3)
Opinion on the Equivalence of supervisory and regulatory requirements in relation to Argentina
Published: 22/05/2019
Art. 107(3)
Opinion on the Equivalence of supervisory and regulatory requirements in relation to Serbia and South Korea
Published: 23/01/2020
Art. 107(3)
Opinion on the Equivalence of Supervisory and Regulatory Requirements in relation to Turkey and New Zealand
Published: 17/12/2015
Art. 107(3)